HMS Announces Appointment of Two New Board Members
June 20 2019 - 9:00AM
HMS Holdings Corp. (Nasdaq: HMSY) today
announced that Katherine Baicker and Jeffrey Rideout have been
named to the Company’s Board of Directors, effective June 20,
2019. These appointments expand the Board to ten directors.
“We are pleased to welcome Kate and Jeff to the
HMS Board,” said Bill Lucia, Chairman and CEO. “Both are
accomplished leaders in their fields of expertise. Kate brings
extensive experience in healthcare policy and economic research to
our Board, and Jeff brings a deep understanding of managed care,
health information technology, value-based care, and quality
clinical outcomes practices. We look forward to benefitting from
their unique, independent perspectives of the changing healthcare
environment as we continue to successfully grow our business and
create long-term value for our shareholders and clients.”
“I am honored and excited to join the HMS Board
of Directors,” commented Dr. Baicker. “I look forward to
working with the Board and management team as we pursue a shared
goal of guiding HMS’ continued innovation and leadership in this
crucial area of the healthcare system.”
“HMS has a proven executive team and a vast
opportunity to leverage its data analytics capabilities to improve
payment accuracy and clinical outcomes for its clients and the
healthcare industry overall,” Dr. Rideout added. “I look forward to
bringing valuable ideas and insights to the Board to help the
Company realize even greater success.”
About Katherine BaickerDr.
Baicker is Dean and the Emmett Dedmon Professor at the University
of Chicago Harris School of Public Policy. She is a leading
scholar in the economic analysis of health policy and currently
serves as a research associate at the National Bureau of Economic
Research. Dr. Baicker’s research has been published in
journals such as the New England Journal of Medicine, JAMA,
Science, Health Affairs, and the Quarterly Journal of Economics.
She is an elected member of the National Academy of Medicine,
National Academy of Social Insurance, and the American Academy of
Arts and Sciences, and also serves on the Congressional Budget
Office’s Panel of Health Advisers and on the Board of Directors of
Eli Lilly. Previously, Dr. Baicker served as the C. Boyden
Gray Professor of Health Economics at Harvard University and was
Chair of Harvard T.H. Chan School of Public Health’s Department of
Health Policy and Management. She also has served as a
Senate-confirmed Member of the President’s Council of Economic
Advisers, as a Commissioner on the Medicare Payment Advisory
Commission, and as Chair of the Massachusetts Group Insurance
Commission. Dr. Baicker earned a bachelor’s degree in
Economics from Yale University and a Ph.D. in Economics from
Harvard University.
About Jeffrey RideoutDr.
Rideout is President and CEO of the Integrated Healthcare
Association, a California-based multi-stakeholder leadership group
that promotes quality improvement, accountability and affordability
of health care. He is also a licensed physician in the State
of California and holds academic appointments at Stanford
University as a Consulting Professor, Department of Health Research
and Policy, School of Medicine, and the University of California,
Berkeley Haas School of Business, where he teaches on topics
related to healthcare technology, services and innovation.
Dr. Rideout also currently serves on the Board of Directors of
Amedisys Corporation. Previously, he served as an independent
consultant to several organizations, including as Senior Medical
Advisor at Covered California, California’s State-based exchange,
and as Senior Advisor to GE Ventures, where he focused on new
business development related to Digital Health and Digital
Therapeutics. Prior to that, Dr. Rideout had served as Chief
Medical Officer for The TriZetto Group, a healthcare information
technology company, as Chief Medical Officer of Cisco Systems and
the global leader of Cisco’s Internet Business Solutions Group
Healthcare Practice, and as SVP and Chief Medical Officer of Blue
Shield of California. Dr. Rideout earned a bachelor’s degree
in Biology from Stanford University, a master’s degree in
Philosophy, Politics and Economics from Oxford University (U.K.)
and a medical degree from Harvard University.
About HMSHMS advances the
healthcare system by helping payers reduce costs and improve health
outcomes. Through our industry-leading technology, analytics and
engagement solutions, we save billions of dollars annually while
helping health plan members lead healthier lives. HMS provides a
broad range of coordination of benefits, payment integrity,
population risk analytics, care management and member engagement
solutions that help move the healthcare system forward. Visit us at
www.hms.com and follow us on Twitter at @HMSHealthcare.
Investor
Contact: |
Media
Contact: |
Robert Borchert |
Lacey Hautzinger |
SVP, Investor Relations |
Sr. Director, External Communications |
robert.borchert@hms.com |
lacey.hautzinger@hms.com |
469-284-2140 |
469-284-7240 |
HMS (NASDAQ:HMSY)
Historical Stock Chart
From Mar 2024 to Apr 2024
HMS (NASDAQ:HMSY)
Historical Stock Chart
From Apr 2023 to Apr 2024